Current Issue
November-December 2016| Vol 2| Issue 6
-
 Table of Contents
-
Original Article
Choline kinase inhibitors synergize with TRAIL in the treatment of colorectal tumors and overcomes TRAIL resistance
Juan Carlos Lacal, Ladislav Andera
Aim: The aim of this study was to investigate the effects of the combination of choline kinase inhibitor MN58b and tumor necrosis factor-related apoptosis inducing ligand (TRAIL) against colon ...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]
Review
MicroRNA regulating metabolic reprogramming in tumor cells: New tumor markers
Daniel Otero-Albiol, Blanca Felipe-Abrio
Metabolic reprogramming is a feature of cancer cells that provides fast energy production and the abundance of precursors required to fuel uncontrolled proliferation. The Warburg effect, increase in g...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]
Review
Biomarkers of colorectal cancer: A genome-wide perspective
José M Santos-Pereira, Sandra Muñoz-Galván
Colorectal cancer (CRC) is one of the most common cancers in the world and one of the main causes of death. Although CRC is among the best-studied cancers and our knowledge about CRC biomarkers and ca...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]
Review
Nicotinamide adenine dinucleotide+ metabolism biomarkers in malignant gliomas
Manuel P Jiménez-García, Eva M Verdugo-Sivianes, Antonio Lucena-Cacace
Gliomas are highly metabolically active tumors. Cancer metabolism is currently of great interest to researchers. Nicotinamide adenine dinucleotide (NAD) is central in cell metabolism. NAD+
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]
Review
Patient-derived xenografts as models for personalized medicine research in cancer
Marco Perez, Lola Navas, Amancio Carnero
Basic research and clinical trials are essential components of the process of discovery and development of new drugs. The use of preclinical models is a key component in every aspect of drug developme...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]
View All Articles in the Current Issue
Abstracting and Indexing Information
The journal is registered with the following abstracting partners:
Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing's Electronic Databases, Exlibris – Primo Central, Google Scholar, Hinari, Infotrieve, Journal Guide, National Science Library, OpenJGate, ProQuest, TdNet
The journal is indexed with, or included in, the following:
DOAJ
Cancer Translational Medicine is an open-access and peer-reviewed online journal with Bimonthly print on demand compilation of issues published. The journal’s free full text is available online at https://cancertm.com
Features of Manuscript Management System
- Online submission
- Wider visibility through open access
- Higher impact
- Prompt review
   
|
